吉林敖东：关于控股子公司获得药品注册证书的自愿性信息披露公告

Group 1 - The core point of the article is that Jilin Aodong has received a drug registration certificate for "Sulfuric Terbutaline Nebulized Inhalation Solution" from the National Medical Products Administration [2] Group 2 - The announcement was made on the evening of September 5, indicating a significant regulatory approval for the company's product [2] - The product is expected to enhance the company's portfolio in the pharmaceutical sector, particularly in respiratory treatments [2] - This approval may lead to increased market opportunities and potential revenue growth for Jilin Aodong [2]